Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma

NCT01247623 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT01247623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01247623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma
Lead sponsor
Oslo University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2005
Completion date
September 30, 2012
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma